Pacira BioSciences Inc. (82P)

Overview

Pacira BioSciences, Inc. is a prominent company operating within the healthcare sector in the United States, focusing on creating innovative non-opioid pain management and regenerative health solutions. Established originally in 2006 and undergoing a name change from Pacira Pharmaceuticals, Inc. to Pacira BioSciences, Inc. in April 2019, the company has dedicated itself to addressing the urgent need for non-opioid therapeutic options. Based in Tampa, Florida, Pacira BioSciences stands at the forefront of developing, manufacturing, marketing, and distributing products designed to offer pain relief and support healing processes without the dependency risks associated with opioids. The company collaborates closely with healthcare practitioners to ensure the accessibility and effectiveness of its solutions, additionally forming strategic partnerships, such as with Aratana Therapeutics, Inc., to enhance its product offerings through development and commercialization agreements.

Products and Services

• EXPAREL

  A cutting-edge bupivacaine liposome injectable suspension, EXPAREL is designed for postsurgical pain management. By utilizing a liposomal delivery system, it provides long-lasting pain relief without the need for opioids, offering a significant advantage in the postoperative care landscape.

• ZILRETTA

  ZILRETTA is an extended-release injectable suspension formulated with triamcinolone acetonide. Engineered to manage osteoarthritis pain, it provides a sustained therapeutic effect, thereby enhancing patient comfort and mobility over an extended period.

• iovera° system

  The iovera° system represents a groundbreaking approach to pain management through handheld cryoanalgesia technology. It works by applying controlled doses of cold to targeted nerves to temporarily reduce pain without drugs, making it an innovative non-opioid treatment option for various conditions.

• NOCITA

  Developed through a strategic partnership with Aratana Therapeutics, Inc., NOCITA is another bupivacaine liposome injectable suspension offered by Pacira. It is specially designed for managing post-surgical pain in pets, extending the company’s non-opioid pain management solutions to the veterinary field.